Brevicidine

General Information


DRACP ID  DRACP04178

Peptide Name   Brevicidine

Sequence  nywxXGxWTIGS

Sequence Length  12

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Native peptide

Classification

  

Active ACP



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial; Antifungal



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  4-ME-C6

C-terminal Modification  Free

Other Modification  None

Chiral  Mix



Physicochemical Information


Formula  C28H29N7O3

Absent amino acids  ACDEFHKLMNPQRVY

Common amino acids  G

Mass  81796

Pl  6.11

Basic residues  0

Acidic residues  0

Hydrophobic residues  2

Net charge  0

Boman Index  316

Hydrophobicity  10.83

Aliphatic Index  32.5

Half Life 
  /

Extinction Coefficient cystines  5500

Absorbance 280nm  500

Polar residues  4

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 34177875

Title  BrevicidineB, a New Member of the Brevicidine Family, Displays an Extended Target Specificity

Doi Not available

Year  2021

Literature 2

Pubmed ID 30115920

Title  Discovery of cationic nonribosomal peptides as Gram-negative antibiotics through global genome mining

Doi Not available

Year  2018

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  18207

DRACP is developed by Dr.Zheng's team.